ONCOSIMIS BIOTECH
  • Home
  • About Us
  • Technologies
  • OnCovid™
  • Pipeline
  • Funding & Awards
  • Contact Us
  • More
    • Home
    • About Us
    • Technologies
    • OnCovid™
    • Pipeline
    • Funding & Awards
    • Contact Us

ONCOSIMIS BIOTECH

  • Home
  • About Us
  • Technologies
  • OnCovid™
  • Pipeline
  • Funding & Awards
  • Contact Us

BacSec® Technology

OSB-1 Liraglutide (Victoza®)

OSB-3 Ranibizumab (Lucentis®)

OSB-1 Liraglutide (Victoza®)

image700

Liraglutide is recombinant peptide control blood glucose level in T2D patients. 

more about this drug

OSB-2 Teriparatide (Forteo®)

OSB-3 Ranibizumab (Lucentis®)

OSB-1 Liraglutide (Victoza®)

image701

Teriparatide is recombinant peptide used to treat osteoporosis in men and women.

more about this drug

OSB-3 Ranibizumab (Lucentis®)

OSB-3 Ranibizumab (Lucentis®)

OSB-3 Ranibizumab (Lucentis®)

image702

Ranibizumab is a Fab used to treat the age-related macular degenerations.

more about this drug

AcceTT®

OSB-4 Aflibercept (Eylea®)

OSB-5 Pembrolizumab (Keytruda®)

OSB-5 Pembrolizumab (Keytruda®)

image703

Aflibercept is a recombinant fusion protein used to treat age-related macular degeneration.

more about this drug

OSB-5 Pembrolizumab (Keytruda®)

OSB-5 Pembrolizumab (Keytruda®)

OSB-5 Pembrolizumab (Keytruda®)

image704

Pembrolizumab is a mAb used in various cancer immunotherapy treatments.

more about this drug

OSB-6 Atezolizumab (Tecentriq®)

OSB-5 Pembrolizumab (Keytruda®)

OSB-6 Atezolizumab (Tecentriq®)

image705

Atezolizumab is a mAb used in various cancer immunotherapy treatments.

more about this drug

What is a Biosimilar?

image706

Biosimilar

A biosimilar is a biologic medical drug that is almost an identical copy of an innovator product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires.

How does medical agencies works to ensure that these biological medicines are as safe and effective as any other medicines? 

image707

List of biosimilars currently in the market worth $100 Bn

Activase®; Advate®; Afrezza®; Aldurazyme®; Apidra®; Aranesp®; Arcalyst®; Avastin®; Avonex®; BeneFIX; Benlysta®; Betaseron®; Bexxar®; Blincyto®; Botox®; Cerezyme®; Cervarix®; ChondroCelect®; Cimzia®; Cyramza®; Elaprase®; Elelyso®; Elonva®; Enbrel®; Entyvio®; Epogen®; Erbitux®; Fabrazyme®; Forteo®; Genotropin®; Gonal-F®; Helixate®; Herceptin®; Humalog®; Humatrope®; Humira®; Humulin R®; Ilaris®; Imvamune®; Increlex®; Intron A®; Ixiaro®; Jetrea®; Kadcyla®; Kalbitor®; Kepivance®; Kineret®; Kogenate®; Lantus®; Lemtrada®; Levemir®; Lucentis®; Luveris®; Macugen®; Mircera®; Myalept®; Myozyme®; Natpara®; Natrecor®; Neulasta®; Neumega®; Neupogen®; Norditropin SimpleXx®; NovoMix 30®; NovoRapid®; NovoSeven®; NovoThirteen®; Nplate®; Nulojix®; Nutropin®; Obizur®; Oncaspar®; Ontak®; Orencia SC®; Orencia®; Antagon®; Orthoclone OKT-3®; Ovidrel®; Pediarix®; Pegasys®; PEGIntron®; Prevnar®; Prochymal®; Procrit®; Proleukin®; Prolia®; Provenge®; Follistim®; Rebif®; Recombivax HB®; Recothrom®; Xyntha®; Remicade®; ReoPro®; Replagal®; Retacrit®; Rituxan®; RotaTeq®; Saxenda®; Serostim®; Simponi®; Simulect®; Soliris®; Somavert®; Stelara®; Synagis®; Tanzeum®; Thyrogen®; Trulicity®; Tysabri®; V419®; Vectibix®; Victoza®; Voraxaze®; Xgeva®; Xolair®; Yervoy®; and Zaltrap®;


Copyright © 2018 Oncosimis® Biotech Pvt Ltd - All Rights Reserved.

Powered by GoDaddy